Funding for this research was provided by:
Prevention and Treatment of High Incidence Diseases in Central Asia Fund (SKL-HIDCA-2020-9)
National Natural Science Foundation of China (72163033)
Article History
Received: 14 April 2022
Accepted: 27 May 2022
First Online: 6 June 2022
Declarations
:
: The study was approved by the Medical Science Research Ethics Committee of Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention, and was in accordance with the Declaration of Helsinki. All participants provided written informed consent for inclusion in the study and could withdraw from the study at any time.
: The authors declare no competing interests.